AAS
IRMD icon

Avantax Advisory Services’s iRadimed IRMD Stock Holding History

Avantax Advisory Services’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$267K Sell
4,465
-81
-2% -$4.44K ﹤0.01% 2007
2025
Q1 		$239K Buy
4,546
+599
+15% +$33.7K ﹤0.01% 1992
2024
Q4 		$217K Buy
+3,947
New +$208K ﹤0.01% 2002

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Avantax Advisory Services's IRMD Position: Q2 2025 in Review

Avantax Advisory Services reduced its iRadimed (IRMD) stake by 1.8% in Q2 2025, selling an estimated $4.44K and leaving 4,465 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #2007.

Avantax Advisory Services first reported a position in IRMD in Q4 2024 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold IRMD as of Q2 2025.

  • Avantax Advisory Services held 4,465 shares of iRadimed worth $267K as of Q2 2025.
  • Avantax Advisory Services sold 81 iRadimed shares in Q2 2025, an estimated $4.44K.
  • iRadimed made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #2007 holding.
  • Avantax Advisory Services first reported a position in iRadimed in Q4 2024 and has held it in 3 quarters since.
  • 162 funds tracked by Wall St. Rank held iRadimed as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.